{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
We partner with international pharmaceutical companies to act as Swiss marketing authorization holder and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced and provide in-depth expertise of commercial operations in domains like oncology and rare diseases. SFL Pharma ha
SFL, a Veristat company, is a leading consultancy providing integrated solutions to pharma, biotech & medtech companies. Our services mirror these sectors' key functions: Regulatory Affairs, Quality & Supply Chain, Medical Writing, Public Affairs & RI, Market Access, PV & Compliance.
SpiroChem is a pioneering CRO covering the entire discovery chemistry value chain, from screening libraries (high-sp3 fragments, covalent fragments, macrocycles) to design (FBDD, SBDD, CADD) and synthesis of bioactive molecules (MedChem-Enabling platforms), all the way to early CMC (Route-Scouting).
We specialize in the development and commercialization of medical devices for dermatology, plastic surgery, burns, radiation oncology, wounds & scar management. Our products are novel type of wound dressings that start as a gel then dry to form silicone gel sheets while on the skin or wound.
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown.
USP is an independent, scientific nonprofit organization. Our standards are public and "open source" and are an important resource for making sure safe, quality medicines reach patients.
VAXIMM is developing oral T-cell immunotherapies for cancer patients. Its technology is based on first-in-class oral T-cell activators, using modified attenuated bacteria carrying a eukaryotic expression plasmid, which enables the targeting of tumor-related antigens, including personalized neoantigens.
The high-growth, high-risk life science journey has its own psychology and context. With expertise that goes beyond finance, we align science, ROI/IRR, and stakeholder motivation. We provide management and boards with clarity on value and readiness, supporting financing, IPO, BD&L and accounting or tax-re